Replies

Thanks for the resignations update.
Tons of information here, https://www.altheal.org/toxicity/icccont.htm

The ICC Investigation Continues
Hospital PR firm gives insufficient response to ICC Investigation
By Liam Scheff, July, 2004

In January, 2004, I published “The House That AIDS Built.” The story dealt with medical abuse at Incarnation Children’s Center (ICC), a home for HIV positive children in New York City. The story exposed the practices of forced-drugging, drug trials without informed consent, and profound medical abuse. The story was picked up by several international papers, including the New York Post and the UK Guardian, and was reprinted throughout the world on the world wide web.

German journalist Torsten Engelbrecht read the story and formulated a series of questions for Columbia Presbyterian, the hospital which presides over ICC. He was answered by a PR firm. The answers were dishonest and unsatisfactory. What follows is a response to and a dissection of their answers using NIH documents, clinical trials, interview material, Medline articles and Department of Health statistics. Given the material provided here, it is clear that the practice of surgical forced-drugging of HIV positive children with toxic compounds is ongoing, in violation of the rights of wards of the state, and must be addressed immediately.

The format is as follows:

Q: First, Torsten Engelbrecht’s (the German journalist) questions (Q).
A: Then the PR group’s answer (A).
Response: Then my response (Response).

More through the link above. Including this,
-A Study to Compare Different Drugs Used to Prevent Serious Bacterial Infections in HIV-Positive Children
Sponsors: NIAID, Pfizer, Glaxo, NICHD
http://www.clinicaltrials.gov/ct/show/NCT00000811?order=1

-The Safety and Effectiveness of Valacyclovir HCI in the Treatment of Herpes Simplex or Varicella/Zoster Infections in HIV-1 Infected Children
Sponsors: NIAID, Glaxo
http://www.clinicaltrials.gov/ct/show/NCT00001054?order=1

A Phase I Study to Evaluate the Safety and Immunogenicity of Recombinant HIV-1 Envelope Antigen in Children Born to HIV-Infected Mothers [March 2004]
Sponsors: NIAID, Genentech, Biocine
http://www.clinicaltrials.gov/ct/show/NCT00000774?order=2

A Randomized Comparative Trial of Zidovudine (AZT) Versus 2’,3’-Dideoxyinosine (ddI) Versus AZT Plus ddI in Symptomatic HIV-Infected Children [Jan 2003]
Sponsored by NIAID, Bristol-Myers Squibb, Glaxo Wellcome
http://www.clinicaltrials.gov/ct/show/NCT00000637?order=3

FAUCI PAID TO TORTURE ORPHANS